August 8, 2025 • 9:00 AM EDT ASP Isotopes Inc. Announces Expected Commencement of Dual Listing on Johannesburg Stock Exchange
July 28, 2025 • 8:31 AM EDT ASP Isotopes Inc. and IsoBio, Inc. Announce Series Seed Funding of IsoBio, Inc. to Advance Innovative Antibody-Isotope Conjugates (AICsTM) For Cancer Treatment
July 25, 2025 • 8:59 AM EDT Competition Commission of South Africa Approves the Offer by ASP Isotopes Inc. for Renergen Limited
July 23, 2025 • 6:15 PM EDT ASP Isotopes Inc. Announces Pricing of $60 Million Underwritten Registered Direct Offering of Common Stock
July 17, 2025 • 8:00 AM EDT ASP Isotopes Inc. Announces Updates on the Progress of Commercial Production at its Three Enrichment Facilities in South Africa
July 11, 2025 • 8:00 AM EDT Shareholders of Renergen Limited Approve Proposed Acquisition by ASP Isotopes Inc.
June 11, 2025 • 8:23 AM EDT ASP Isotopes Inc. Enhances the Quantum Leap Energy LLC (QLE) Executive Leadership Team with the Appointment of Ryno Pretorius as Chief Executive Officer of QLE
June 4, 2025 • 9:00 AM EDT ASP Isotopes Inc. to host Investor Access Event in South Africa from June 16-18, 2025
June 4, 2025 • 8:30 AM EDT ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies
June 2, 2025 • 9:15 AM EDT ASP Isotopes Inc. Announces Pricing of $50 Million Underwritten Registered Direct Offering of Common Stock
